Getting {Beyond} Cancer

ImClone is a vertically integrated bio-pharmaceutical company with one approved cancer therapy called Erbitux and a promising pipeline. ImClone
is profitable, progressive and committed to the advancement of oncology.

The Magic: While cancer may always be a fact of life, we see a time where
it no longer threatens life.

The Vision: Getting {Beyond} Cancer – an intimate journey into the lives of three real Erbitux patients who are getting beyond cancer and getting on with

their lives. These impressionistic photo-essays of real life capture seemingly
mundane, but essential moments about survival, life, endurance, time and hope.

The Experience: 1919 created an Annual Report for ImClone that delivered the vision and mission of the company with a compelling emotional narrative about three patients who have benefited from Erbitux coupled with a Letter to Shareholders about the progress of the Erbitux franchise and the status of the pipeline, partner-
ships and finances. All photography is by 1919 Creative Director Peter Klueger. An annual report for 2005 that truly manifests humanity, vision and purpose.